Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 5:31 PM ET

Date/Time Source News Release
05/15/2025 02:30 PM EDT GlobeNewswire RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
05/07/2025 02:30 PM EDT GlobeNewswire Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
05/06/2025 01:40 PM EDT GlobeNewswire Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
04/30/2025 12:50 PM EDT GlobeNewswire Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
04/16/2025 12:45 PM EDT GlobeNewswire Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
04/09/2025 01:40 PM EDT GlobeNewswire Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
04/08/2025 10:45 AM EDT GlobeNewswire Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
02/26/2025 11:30 AM EST ACCESS Newswire Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
02/18/2025 08:30 AM EST ACCESS Newswire Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
02/11/2025 10:15 AM EST ACCESS Newswire Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
Page

Additional News

As of June 4, 2025 • 5:31 PM ET

Date/Time Source News Release
05/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cosmos Health Inc.
04/08/2025 11:48 AM EDT SeekingAlpha Cosmos Health launches Sky Premium Life in Albania, secures $0.3M order
01/13/2025 09:55 AM EST SeekingAlpha Cosmos Health announces distribution agreement with Virax Biolabs
12/18/2024 05:44 PM EST SeekingAlpha Cosmos Health files to sell common stock, warrants
11/20/2024 06:08 PM EST SeekingAlpha Henry Schein: Another Day, Another Purchase
11/16/2024 04:36 AM EST US Earnings Reports Expected earnings - Cosmos Health Inc.
11/14/2024 08:40 AM EST Zacks Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates
11/13/2024 05:20 PM EST Zacks 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
11/12/2024 05:55 PM EST Zacks Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
11/07/2024 08:15 AM EST Zacks Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.